PT - JOURNAL ARTICLE AU - Constantine Vardavas AU - Katerina Nikitara AU - Alexander Mathioudakis AU - Michele Hilton-Boon AU - Revati Phalkey AU - Jo Leonardi-Bee AU - Anastasia Pharris AU - Charlotte Deogan AU - Jonathan E. Suk TI - The role of educational settings in the transmission chain of SARS-CoV-2 in 2020: a systematic review AID - 10.1101/2021.10.13.21264932 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.13.21264932 4099 - http://medrxiv.org/content/early/2021/10/16/2021.10.13.21264932.short 4100 - http://medrxiv.org/content/early/2021/10/16/2021.10.13.21264932.full AB - Background School closures have been used as a core Non pharmaceutical intervention during the COVID-19 pandemic, however the role of educational settings in COVID-19 transmission is still unclear.Methods This systematic literature review assessed studies published between December 2019 and April 1, 2021 in Medline and Embase, which included studies that assessed educational settings from approximately January 2020 to January 2021. The inclusion criteria were based on the PCC framework (P-Population, C-Concept, C-Context). The study Population was restricted to people 1-17 years old (excluding neonatal transmission), the Concept was to assess child-to-child and child-to-adult transmission, while the Context was to assess specifically educational setting transmission clusters.Results Fifteen studies met inclusion criteria, ranging from daycare centers to high schools and summer camps, while eight studies assessed the re-opening of schools in the 2020-2021 school year. In principle although there is sufficient evidence that children can both be infected by and transmit SARS-CoV-2 in school settings, the SAR remain relatively low -when NPI measures are implemented in parallel. Moreover, although the evidence was limited there was an indication that younger children may have a lower SAR than adolescents.Conclusions Transmission in educational settings in 2020 was minimal -when NPI measures were implemented in parallel. However, with an upsurge of cases related to variants of concern, continuous surveillance and assessment of the evidence is warranted to ensure the maximum protection of the health of students and the educational workforce, while also minimising the numerous negative impacts that school closures may have on children.Strengths and limitations of this studyThis study provides a rapid review of the peer-reviewed literature pertaining to SARS-CoV-2 transmission by children within educational settings.The review reflects the status quo of the previous school years (January 2020 -January 2021) due to the lag time between study implementation, peer review and publication.The included studies represent child-to-child transmission within the context of previous SARS-CoV-2 strains and are not directly applicable to newer variants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis report was produced under a service contract 6-ECD.11297, within Framework contract ECDC/2019/001 Lot 1B, with the European Centre for Disease Prevention and Control (ECDC), acting under the mandate from the European Commission. The information and views set out in this piece of work are those of the authors and do not necessarily reflect the official opinion of the Commission/Agency. The Commission/Agency do not guarantee the accuracy of the data included in this analysis. Neither the Commission/Agency nor any person acting on the Commission's/Agency's behalf may be held responsible for the use which may be made of the information contained therein.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data have been produced. It is a systematic review.